Latest Breaking News On - ஜெனிபர் ஆஷ்டன் - Page 6 : comparemela.com

FatCamera/iStock(NEW YORK) Pfizer announced Tuesday it is moving forward with the final phase of clinical trials for its COVID-19 vaccine, meaning kids as young as five are one step closer to being able to be vaccinated. Pfizer's new study of more than 4,500 children in four countries, including the United States, will see children ages 11 and under receive a smaller dose of the COVID-19 vaccine than adults. Children in the trial will receive a 0.01mL dose of the vaccine, compared to the two doses of 0.3 mL each that kids ages 12 and older and adults receive. In the coming weeks, Pfizer said it plans to launch a Phase 2/3 trial in children ages 2 to 4 years and then children ages six months to 2 years with an even smaller dose of the vaccine. "We take a deliberate and careful approach to help us understand the safety and how well the vaccine can be tolerated in younger children," Bill Gruber, M.D., senior vice president of clinical research and development at Pfizer, s

United statesUnited kingdomPeter marksJennifer ashtonLee savio beersAmerican academy of pediatricsUs department of healthHuman servicesDrug administrationAmerican academyBiologics evaluationஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்பீட்டர் மதிப்பெண்கள்ஜெனிபர் ஆஷ்டன்லீ சவிஓ பியர்ஸ்